Want to join the conversation?
Sanford Bernstein analyst Toni Sacconaghi probes $IBM whether metrics of company & software revenues falling 4% & about 5% or more respectively are correct. CFO Martin Schroeter says that acquisitions are part of $IBM, so total was company revenue. On an acquisitive impact, it was about 2 points. Software dynamic was similar to past few quarters.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?